Description

1H-Azepine-1-Acetamide, n-(3-(2-Furanyl)-5-Isoxazolyl)Hexahydro-, Mono Hydrochloride is a specialized heterocyclic organic compound with a complex molecular architecture, offered as a high-purity hydrochloride salt. This compound is valued for its role as a critical pharmaceutical intermediate and a versatile building block in advanced organic synthesis, enabling the development of novel active ingredients. It is primarily sought by research institutions, pharmaceutical R&D laboratories, and fine chemical manufacturers engaged in medicinal chemistry and process development.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly in central nervous system (CNS) and anti-inflammatory therapeutic areas.
• Medicinal Chemistry Research: Serves as a sophisticated scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Fine Chemical Synthesis: Used in the multi-step synthesis of complex heterocyclic compounds for agrochemical and material science applications.
• Biochemical Tool Compound: Potential utility in developing probes for studying biological pathways and enzyme interactions in academic and industrial research.
• Process Development & Scale-up: Employed by CROs and CDMOs for developing and optimizing robust, scalable synthetic routes for API manufacturing.

Basic Information

Product Name	1H-Azepine-1-Acetamide, n-(3-(2-Furanyl)-5-Isoxazolyl)Hexahydro-, Mono Hydrochloride
CAS No.	37853-39-7
Molecular Formula	C16H22N4O3 • HCl
Molecular Weight	354.83 g/mol (Free base: 318.37 g/mol)
Synonyms	Hexahydro-1H-azepine-1-acetamide, N-[3-(2-furanyl)-5-isoxazolyl]-, monohydrochloride; N-(3-(2-Furyl)-5-isoxazolyl)hexahydro-1H-azepine-1-acetamide hydrochloride; 1-Azepineacetamide, N-[3-(2-furanyl)-5-isoxazolyl]hexahydro-, monohydrochloride; Furosemide related compound (structural analog); 37853-39-7
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to stringent quality management systems. Every batch is characterized and tested using advanced analytical techniques including HPLC, NMR, and mass spectrometry to ensure identity, purity, and consistency. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with each shipment. We support development and cGMP-grade manufacturing for pharmaceutical applications, with quality standards tailored to client requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed after opening to prevent moisture absorption. For long-term storage, consider using desiccants or an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Individual impurity ≤ 0.5%; Total impurities ≤ 1.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.